Medicament for treating primary bronchogenic carcinoma

A bronchial lung cancer, primary technology, applied in the direction of drug combination, pharmaceutical formula, medical raw materials derived from mammals, etc., can solve the problems of high price, low cure rate, unattainable treatment plan, etc., and achieves quick effect and non-toxicity. Side effects, the effect of easy preparation of drugs

Inactive Publication Date: 2013-06-26
李运乃
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Problems exist. The diagnosis and treatment of lung cancer patients mostly adopt traditional Western medicine treatment schemes, emerging interventional treatment and biological treatment, etc. The cure rate of these treatment methods is too low and the price is relatively expensive.
Based on the theory of traditional Chinese medicine, Dr. Yu set up the green treatment concept of using pure traditional Chinese medicine to strengthen the body and dispel pathogens, eliminate cancer poison, and both attack and supplement. The patient has brought great confidence, and there is no harm to the patient's body during the treatment process, these are the medical effects that cannot be achieved by the treatment options currently on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] Embodiments are described in detail below:

[0014] Method 1. Set up and develop a small batch of medical compound lung cancer capsules. Take 20g of ginseng, 30g of astragalus, 30g of Hedyotis diffusa, 20g of cat’s claw, 3g of saffron, 6g of Panax notoginseng powder, 0.15g of musk, 15g of lobelia, Curcuma 15g, Lingxiaohua 10g, Cyperus cyperi 10g, peach kernel 10g, Zhizhizi 10g, gecko 30g, cordyceps sinensis 20g, broken ganoderma lucidum spore powder 30g, Chinese medicinal materials and packaging materials. It is a kind of drug preparation for treating primary bronchial lung cancer by taking appropriate amount of ingredients of traditional Chinese medicine, through authentic selection of materials, conventional processing, drying and drying on low heat, and packing into a small bag of raw materials for treating primary bronchial lung cancer. The raw materials in bags are processed and pulverized into 120-mesh fine powder by a small electric pulverizer, and then processed...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating primary bronchogenic carcinoma. Compound lung cancer capsule preparation consists of the following traditional Chinese medicines and packaging materials: ginseng, astragalus mongholicus, oldenlandia diffusa, ternate buttercup root, saffron crocus, pseudo-ginseng powder, musk, Chinese lobelia, curcuma zedoary, campsis grandiflora, rhizoma cyperi, peach kernel, akebia fruit, wall gecko, cordyceps sinensis and reishi shell-broken spore powder. The medicament disclosed by the invention fills up the blank in the subject filed for preventing and treating primary bronchogenic carcinoma-caused cough, hemoptysis, chest pain, phlegm and retained fluid, phlegm poison, lung poison, lung atelectasis, lung lump, lung accumulation and rushing respiration as well as pulmonary respiration-pulmonary atelectasis-caused deficiency of vital energy, imbalance of yin and yang, lung attacks due to deficiency of vital energy, qi depression of lung, disturbance of diffusion and downbearing, qi stagnation and blood stasis, phlegm cementation and lung cancers caused by lasting lung diseases. The medicament is innovative for the existing Chinese medicine treatment of the human in the world to lung cancer recovery clinical care culture.

Description

technical field [0001] The invention belongs to a medicine for treating primary bronchial lung cancer, that is, a compound lung cancer capsule preparation. Background technique [0002] Primary bronchial lung cancer, referred to as lung cancer, refers to malignant tumors that originate in bronchial mucosa and alveoli, and is one of the most common malignant tumors. According to authoritative data statistics compiled by the old man and published for the first time in January 1996, the male standardized mortality rate was 10.3 / 100,000, the fourth malignant tumor; the female standardized mortality rate was 4.8 / 100,000. It is the fifth malignant tumor. The disease is more likely to occur in men over the age of 40 who have a long-term smoking history, and exposure to carcinogens (such as arsenic, asbestos, chromium, nickel, coal tar, asphalt smoke, dichloromethyl ether, chloromethyl ether, etc.) , formaldehyde, dust, etc.), ionizing radiation, water pollution, air pollution, ge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P11/00A61P35/00A61K35/56A61K35/55A61K35/583
Inventor 李运乃
Owner 李运乃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products